Demographics | N = 19 |
Age, mean±SD | 71±11.6 |
Sex, n (%) | |
Female | 17 (89) |
Male | 2 (10.5) |
Race, n (%) | |
African American | 5 (27.8) |
Caucasian | 9 (50.0) |
Hispanic | 2 (11.1) |
Other | 2 (11.1) |
Missing | 1 |
Hemorrhagic transformation, n (%) | |
PH3c | 2 (10.5) |
HI1 | 5 (26.3) |
PH1 | 3 (15.8) |
PH2 | 1 (5.3) |
No | 8 (42.1) |
Discharge disposition, n (%) | 11 (57.9) |
Acute rehabilitation | 1 (5.3) |
Home | 4 (21.0) |
Hospice | 3 (15.8) |
Dead | 1 (5.3) |
Patient alive at end of 1 year, n (%) | 9 (60.0) |
Missing | 4 |
Able to continue cancer treatment after thrombectomy, n (%) | 7 (47) |
Missing | 4 |
Location and type of primary tumor and metastasis, n (%) | |
Breast cancer | 3 (15.8) |
Gastrointestinal | 2 (10.5) |
Hematological | 2 (10.5) |
Hepatobiliary | 1 (5.3) |
Lung adenocarcinoma | 5 (26.3) |
Small cell carcinoma of lung | 1 (5.3) |
Prostate cancer | 1 (5.3) |
Urogenital | 4 (21.1) |
HI, hemorrhagic infarction; PH, parenchymal hematoma.